Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

mavacoxib

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Selective COX-2 inhibitors are non-steroidal anti-inflammatory drugs which directly target cyclooxygenase-2 (COX-2), an enzyme… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2015
2015
Iridium-catalyzed C–H activation and ortho-hydrogen isotope exchange is an important technology for allowing access to labeled… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
A multi-site, masked, randomised parallel group study employing a double dummy treatment design was performed in canine… Expand
Is this relevant?
2014
2014
NSAIDs are the cornerstone of medical management of canine osteoarthritis (OA). Meloxicam is a daily-administered NSAID widely… Expand
Is this relevant?
2014
2014
BackgroundThe NSAID mavacoxib (Trocoxil™) is a recently described selective COX-2 inhibitor used for the management of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Osteosarcoma is the most common primary bone tumour of both children and dogs. It is an aggressive tumour in both species with a… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
In the present study based on clinical case reports, twelve dogs (7 males, 5 females) between the ages of 5 and 11 years old… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
Is this relevant?
2013
2013
Received: Revised: Accepted: October 11, 2012 December 12, 2012 December 17, 2012 The aim of this study was to assess the… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Mavacoxib (Trocoxil™) is an oral long-acting COX-2 inhibitor approved for the treatment of osteoarthritis in dogs. Two field… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
2010
2010
The pharmacokinetics of mavacoxib were evaluated in an absolute bioavailability study, a dose-proportionality study and a multi… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?